(Q38189740)

30 August 2017

1 reference

title

Epigenetics and cervical cancer: from pathogenesis to therapy (English)

1 reference

30 August 2017

0 references

cervix uterine cancer

1 reference

Jinchuan Fang

1

1 reference

30 August 2017

Hai Zhang

series ordinal

2

1 reference

30 August 2017

Sufang Jin

series ordinal

3

1 reference

30 August 2017

language of work or name

1 reference

20 February 2014

1 reference

30 August 2017

1 reference

30 August 2017

volume

35

1 reference

30 August 2017

issue

6

1 reference

30 August 2017

page(s)

5083-5093

1 reference

Sexually transmitted infections among US women and men: prevalence and incidence estimates, 2008.

30 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Chapter 1: HPV in the etiology of human cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Epigenetic alterations in preneoplastic and neoplastic lesions of the cervix

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Aberrant CpG-island methylation has non-random and tumour-type-specific patterns.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Chromatin modifications and their function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Long non-coding RNAs: insights into functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Noncoding RNAs in cancer and cancer stem cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Human papillomavirus and cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Molecular mechanisms of cervical carcinogenesis by high-risk human papillomaviruses: novel functions of E6 and E7 oncoproteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Viral epigenomes in human tumorigenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Human papillomavirus oncoproteins: pathways to transformation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Papillomavirus genome structure, expression, and post-transcriptional regulation

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Basic mechanisms of high-risk human papillomavirus-induced carcinogenesis: roles of E6 and E7 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Genetic determinants of cancer metastasis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Epigenetic alterations in cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Role of epigenomics in ovarian and endometrial cancers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

21 January 2018

Epigenetics in cancer

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Epigenetics of cervical cancer. An overview and therapeutic perspectives

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

The epigenomics of cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

p16 methylation does not affect protein expression in cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

P16 methylation is an early event in cervical carcinogenesis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Human papillomavirus immortalization and transformation functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

p16INK4A overexpression in precancerous and cancerous lesions of the uterine cervix in Tunisian women

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Human papillomavirus E7 oncoprotein induces KDM6A and KDM6B histone demethylase expression and causes epigenetic reprogramming

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Tumor suppressor p16INK4A is necessary for survival of cervical carcinoma cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Novel missense mutation in FHIT gene: interpreting the effect in HPV-mediated cervical cancer in Indian women.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Hypermethylation and loss of heterozygosity of tumor suppressor genes on chromosome 3p in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Role of 5'-CpG island hypermethylation of the FHIT gene in cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Functions of cyclin A1 in the cell cycle and its interactions with transcription factor E2F-1 and the Rb family of proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Human papillomavirus's physical state and cyclin A1 promoter methylation in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Cyclin A1 promoter hypermethylation in human papillomavirus-associated cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Death-associated protein kinase (DAPK) and signal transduction: regulation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Assessment of DNA methylation for the detection of cervical neoplasia in liquid-based cytology specimens.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

The role of RASSF1A methylation in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Detection of hypermethylated genes in tumor and plasma of cervical cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Utility of methylation markers in cervical cancer early detection: appraisal of the state-of-the-science

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

The hypermethylation and protein expression of p16 INK4A and DNA repair gene O6-methylguanine-DNA methyltransferase in various uterine cervical lesions.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Adenomatous polyposis coli (APC): a multi-functional tumor suppressor gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Differential DNA methylation profiles in gynecological cancers and correlation with clinico-pathological data

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Sequential gene promoter methylation during HPV-induced cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Comparison of DNA hypermethylation patterns in different types of uterine cancer: cervical squamous cell carcinoma, cervical adenocarcinoma and endometrial adenocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Retinoid, retinoic acid receptor beta and breast cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Methylation and silencing of the retinoic acid receptor-beta 2 gene in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Retinoic acid receptor beta2 is epigenetically silenced either by DNA methylation or repressive histone modifications at the promoter in cervical cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Epigenetic and genetic alternation of PTEN in cervical neoplasm.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Aberrant promoter methylation and silencing of the POU2F3 gene in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Association between dense CADM1 promoter methylation and reduced protein expression in high-grade CIN and cervical SCC.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Alterations of ATM and CADM1 in chromosomal 11q22.3-23.2 region are associated with the development of invasive cervical carcinoma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Frequent promoter methylation of CDH1, DAPK, RARB, and HIC1 genes in carcinoma of cervix uteri: its relationship to clinical outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

IGSF4 promoter methylation and expression silencing in human cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

TSLC1 gene silencing in cervical cancer cell lines and cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

p73 expression is associated with the cellular radiosensitivity in cervical cancer after radiotherapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Discovery of novel methylation biomarkers in cervical carcinoma by global demethylation and microarray analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Assessment of gene promoter hypermethylation for detection of cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Helicase-like transcription factor confers radiation resistance in cervical cancer through enhancing the DNA damage repair capacity.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Translating the Histone Code

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Epigenetic silencing of the WNT antagonist DICKKOPF-1 in cervical cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Human papillomavirus E7 enhances hypoxia-inducible factor 1-mediated transcription by inhibiting binding of histone deacetylases

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Methylated DNA and MeCP2 recruit histone deacetylase to repress transcription

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

DNA methylation and histone modification regulate silencing of OPG during tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

HDAC1/DNMT3A-containing complex is associated with suppression of Oct4 in cervical cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNAs: target recognition and regulatory functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNAs in organogenesis and disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Impaired microRNA processing enhances cellular transformation and tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

A small piece in the cancer puzzle: microRNAs as tumor suppressors and oncogenes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Aberrant expression of oncogenic and tumor-suppressive microRNAs in cervical cancer is required for cancer cell growth

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-361-5p facilitates cervical cancer progression through mediation of epithelial-to-mesenchymal transition

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

miR-196a targets netrin 4 and regulates cell proliferation and migration of cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

OCT4 promotes tumorigenesis and inhibits apoptosis of cervical cancer cells by miR-125b/BAK1 pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

miR-203 suppresses tumor growth and angiogenesis by targeting VEGFA in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-196b regulates the homeobox B7-vascular endothelial growth factor axis in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Circulating miRNA-20a and miRNA-203 for screening lymph node metastasis in early stage cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

miR-375 is down-regulated in squamous cervical cancer and inhibits cell migration and invasion via targeting transcription factor SP1.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-7 downregulates XIAP expression to suppress cell growth and promote apoptosis in cervical cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Upregulation of microRNA-224 is associated with aggressive progression and poor prognosis in human cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-497 is a potential prognostic marker in human cervical cancer and functions as a tumor suppressor by targeting the insulin-like growth factor 1 receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Large-scale screening identifies a novel microRNA, miR-15a-3p, which induces apoptosis in human cancer cell lines

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-214 suppresses growth and invasiveness of cervical cancer cells by targeting UDP-N-acetyl-α-D-galactosamine:polypeptide N-acetylgalactosaminyltransferase 7.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-182 plays an onco-miRNA role in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

miR-205 expression promotes cell proliferation and migration of human cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MiR-17-5p targets TP53INP1 and regulates cell proliferation and apoptosis of cervical cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-19a and -19b regulate cervical carcinoma cell proliferation and invasion by targeting CUL5.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Suppressed miR-424 expression via upregulation of target gene Chk1 contributes to the progression of cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Glucocorticoid regulation of a novel HPV-E6-p53-miR-145 pathway modulates invasion and therapy resistance of cervical cancer cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-133b is a key promoter of cervical carcinoma development through the activation of the ERK and AKT1 pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-372 is down-regulated and targets cyclin-dependent kinase 2 (CDK2) and cyclin A1 in human cervical cancer, which may contribute to tumorigenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Reduced miR-100 expression in cervical cancer and precursors and its carcinogenic effect through targeting PLK1 protein.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Upregulation of p18Ink4c expression by oncogenic HPV E6 via p53-miR-34a pathway

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-34a suppresses invasion through downregulation of Notch1 and Jagged1 in cervical carcinoma and choriocarcinoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA miR-886-5p inhibits apoptosis by down-regulating Bax expression in human cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Methylation-mediated silencing and tumour suppressive function of hsa-miR-124 in cervical cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Methylation-mediated transcriptional repression of microRNAs during cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Exploration of tumor-suppressive microRNAs silenced by DNA hypermethylation in cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Functional evidence that Drosha overexpression in cervical squamous cell carcinoma affects cell phenotype and microRNA profiles

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Global microRNA profiles in cervical squamous cell carcinoma depend on Drosha expression levels.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Human papillomavirus 16 E5 modulates the expression of host microRNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Evolution and functions of long noncoding RNAs

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Long noncoding RNAs: functional surprises from the RNA world

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Long noncoding RNA involvement in cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

HOTAIR is a negative prognostic factor and exhibits pro-oncogenic activity in pancreatic cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Long noncoding RNA associated with microvascular invasion in hepatocellular carcinoma promotes angiogenesis and serves as a predictor for hepatocellular carcinoma patients' poor recurrence-free survival after hepatectomy

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Chromatin signature reveals over a thousand highly conserved large non-coding RNAs in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Aberrant expression of long noncoding RNAs in cervical intraepithelial neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Long non-coding RNA MEG3 inhibits the proliferation of cervical carcinoma cells through the induction of cell cycle arrest and apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Aberrant DNA methylation in cervical carcinogenesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Liquid compared with conventional cervical cytology: a systematic review and meta-analysis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Cervical dysplasia: assessing methylation status (Methylight) of CCNA1, DAPK1, HS3ST2, PAX1 and TFPI2 to improve diagnostic accuracy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

An upward trend in DNA p16ink4a methylation pattern and high risk HPV infection according to the severity of the cervical lesion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Alterations of RASSF1A in premalignant cervical lesions: clinical and prognostic significance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

CADM1 and MAL promoter methylation levels in hrHPV-positive cervical scrapes increase proportional to degree and duration of underlying cervical disease.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Evaluation of candidate methylation markers to detect cervical neoplasia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Expression of mir-21 and mir-143 in cervical specimens ranging from histologically normal through to invasive cervical cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Reduced miR-34a expression in normal cervical tissues and cervical lesions with high-risk human papillomavirus infection.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Testing for methylated PCDH10 or WT1 is superior to the HPV test in detecting severe neoplasms (CIN3 or greater) in the triage of ASC-US smear results

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Triage of cervical cytological diagnoses of atypical squamous cells by DNA methylation of paired boxed gene 1 (PAX1).

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Quantitative methylation-specific PCR for the detection of aberrant DNA methylation in liquid-based Pap tests

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Detection of hypermethylated genes in women with and without cervical neoplasia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Hydralazine inhibits human cervical cancer cell growth in vitro in association with APC demethylation and re-expression

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

A phase I study of hydralazine to demethylate and reactivate the expression of tumor suppressor genes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

The effects of DNA methylation and histone deacetylase inhibitors on human papillomavirus early gene expression in cervical cancer, an in vitro and clinical study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Valproic acid and butyrate induce apoptosis in human cancer cells through inhibition of gene expression of Akt/protein kinase B

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

Histone deacetylase inhibitor apicidin downregulates DNA methyltransferase 1 expression and induces repressive histone modifications via recruitment of corepressor complex to promoter region in human cervix cancer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

MicroRNA-21 promotes cell proliferation and down-regulates the expression of programmed cell death 4 (PDCD4) in HeLa cervical carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS13277-014-1737-Z

miR-99 inhibits cervical carcinoma cell proliferation by targeting TRIB2

21 January 2018

1 reference

12 December 2020

Inhibition of histone deacetylase 2 increases apoptosis and p21Cip1/WAF1 expression, independent of histone deacetylase 1

1 reference

12 December 2020

MicroRNA-10a targets CHL1 and promotes cell growth, migration and invasion in human cervical cancer cells

1 reference

12 December 2020

Tumor suppressive microRNA-218 inhibits cancer cell migration and invasion by targeting focal adhesion pathways in cervical squamous cell carcinoma

1 reference

12 December 2020

CDH1 and CDH13 methylation in serum is an independent prognostic marker in cervical cancer patients

1 reference

12 December 2020

Gene promoter methylation patterns throughout the process of cervical carcinogenesis.

1 reference

12 December 2020

Correlation of promoter hypermethylation in hTERT, DAPK and MGMT genes with cervical oncogenesis progression

1 reference

12 December 2020

Human papillomavirus infection, cancer & therapy

1 reference

12 December 2020

miR-20a promotes migration and invasion by regulating TNKS2 in human cervical cancer cells

1 reference

12 December 2020

MicroRNAs: critical mediators of differentiation, development and disease

1 reference

12 December 2020

Histone deacetylase inhibitors inducing human cervical cancer cell apoptosis by decreasing DNA-methyltransferase 3B.

1 reference

12 December 2020

Synergistic induction of apoptosis in HeLa cells by the proteasome inhibitor bortezomib and histone deacetylase inhibitor SAHA.

1 reference

12 December 2020

Cervical cancer: a preventable death.

1 reference

12 December 2020

The RASSF1A tumor suppressor gene is commonly inactivated in adenocarcinoma of the uterine cervix.

1 reference

12 December 2020

Promoter hypermethylation of multiple genes in carcinoma of the uterine cervix

1 reference

12 December 2020

Reactivation of tumor suppressor genes by the cardiovascular drugs hydralazine and procainamide and their potential use in cancer therapy

1 reference

12 December 2020

Repression of miR-126 and upregulation of adrenomedullin in the stromal endothelium by cancer-stromal cross talks confers angiogenesis of cervical cancer.

1 reference

12 December 2020

Epigenetic regulation of O6-methylguanine-DNA methyltransferase gene expression by histone acetylation and methyl-CpG binding proteins.

1 reference

12 December 2020

[Promoter methylation of DAPK1, RAR-β and MGMT in exfoliated cervical cytology and its clinical application]

1 reference

12 December 2020

Profiling of microRNA-mRNA reveals roles of microRNAs in cervical cancer.

1 reference

12 December 2020

High-risk human papillomavirus reduces the expression of microRNA-218 in women with cervical intraepithelial neoplasia

1 reference

12 December 2020

Trichosanthin inhibits DNA methyltransferase and restores methylation-silenced gene expression in human cervical cancer cells

1 reference

12 December 2020

MiR-125b inhibits tumor growth and promotes apoptosis of cervical cancer cells by targeting phosphoinositide 3-kinase catalytic subunit delta

1 reference

12 December 2020

MiR-21 is involved in cervical squamous cell tumorigenesis and regulates CCL20.

1 reference

12 December 2020

Negative and positive regulation of HIF-1: a complex network

1 reference

12 December 2020

Tumor-suppressive microRNA-29a inhibits cancer cell migration and invasion via targeting HSP47 in cervical squamous cell carcinoma.

1 reference

12 December 2020

MiR-214 reduces cell survival and enhances cisplatin-induced cytotoxicity via down-regulation of Bcl2l2 in cervical cancer cells

1 reference

12 December 2020

Inactivation of RAS association domain family 1A gene in cervical carcinomas and the role of human papillomavirus infection

1 reference

12 December 2020

Expression of MiR200a, miR93, metastasis-related gene RECK and MMP2/MMP9 in human cervical carcinoma--relationship with prognosis.

1 reference

12 December 2020

Infection of human papillomaviruses in cancers of different human organ sites

1 reference

12 December 2020

miR-143 is downregulated in cervical cancer and promotes apoptosis and inhibits tumor formation by targeting Bcl-2.

1 reference

12 December 2020

10.1007/S13277-014-1737-Z

Identifiers

DOI

1 reference

Dimensions Publication ID

30 August 2017

1000833429

0 references

1 reference